Cargando…
Interleukin-25 Mediates Transcriptional Control of PD-L1 via STAT3 in Multipotent Human Mesenchymal Stromal Cells (hMSCs) to Suppress Th17 Responses
Multipotent human mesenchymal stromal cells (hMSCs) harbor immunomodulatory properties that are therapeutically relevant. One of the most clinically important populations of leukocytes is the interleukin-17A (IL-17A)-secreting T (Th17) lymphocytes. However, mechanisms of hMSC and Th17 cell interacti...
Autores principales: | Wang, Wei-Bei, Yen, Men-Luh, Liu, Ko-Jiunn, Hsu, Pei-Ju, Lin, Ming-Hong, Chen, Pei-Min, Sudhir, Putty-Reddy, Chen, Chein-Hung, Chen, Chung-Hsuan, Sytwu, Huei-Kang, Yen, B. Linju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618596/ https://www.ncbi.nlm.nih.gov/pubmed/26321145 http://dx.doi.org/10.1016/j.stemcr.2015.07.013 |
Ejemplares similares
-
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells
por: Chen, Pei-Min, et al.
Publicado: (2011) -
Multipotent Human Mesenchymal Stromal Cells Mediate Expansion of Myeloid-Derived Suppressor Cells via Hepatocyte Growth Factor/c-Met and STAT3
por: Yen, B. Linju, et al.
Publicado: (2013) -
Resident vs nonresident multipotent mesenchymal stromal cell interactions with B lymphocytes result in disparate outcomes
por: Lee, Wei, et al.
Publicado: (2021) -
Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials
por: Wang, Li-Tzu, et al.
Publicado: (2016) -
HLA-G Expression in Human Mesenchymal Stem Cells (MSCs) Is Related to Unique Methylation Pattern in the Proximal Promoter as well as Gene Body DNA
por: Yen, B. Linju, et al.
Publicado: (2020)